期刊文献+

Caveolin-1与MMP-2在食管癌的表达及临床意义 被引量:6

Expression of Caveolin-1 and MMP-2 in esophageal carcinoma and its clinical significance
下载PDF
导出
摘要 目的探讨Caveolin-1与MMP-2在食管鳞癌组织中的表达及其临床意义。方法应用组织芯片技术结合免疫组织化学检测63例食管鳞癌组织,20例食管鳞状上皮非典型增生及15例正常食管鳞状上皮中Caveolin-1与MMP-2蛋白的表达。结果食管癌中Caveolin-1与MMP-2的表达高于正常食管黏膜、非典型增生食管黏膜(P<0.05);Caveolin-1的表达与淋巴结转移、病理学分级及临床分期有关,而与患者的年龄、性别,肿瘤大小、浸润深度无关(P>0.05);MMP-2的表达与淋巴结转移、浸润深度有关,而与患者的年龄、性别,肿瘤大小、病理分级及临床分期无关(P>0.05)。Spearman等级相关分析显示Caveolin-1与MMP-2表达呈正相关(r=0.390,P=0.002)。结论 Caveolin-1与MMP-2过表达与食管癌的发展、浸润及转移有关,Caveolin-1可能上调MMP-2的活性。 Objective To study the expression of Caveolin-1 and MMP-2 proteins in esophageal squamous cell carcinoma and its clinical significance.Methods Caveolin-1 and MMP-2 proteins were tested by immunohistochemistry and tissue microarray in 63 cases of esophageal squamous cell carcinoma,20 cases of atypical hyperplasia and 15 cases of normal esophageal squamous cell.Results The expressions of Caveolin-1 and MMP-2 were significantly higher in esophageal carcinoma than those in normal esophageal mucosa and esophageal dysplasia(P〈0.05);Caveolin-1 expression in esophageal carcinoma was correlated with lymph node metastasis,pathological grade and clinical stage,but not with age,gender,tumor size and invasive depth(P〉0.05).MMP-2 expression in esophageal carcinoma was correlated with lymph node metastasis and depth of invasion,but not with age,gender,tumor size,pathological grade and clinical stage(P〉0.05).Spearman rank correlation analysis showed that the expression of Caveolin-1 was positively correlated with MMP-2(r=0.390,P=0.002).Conclusion The over-expression of Caveolin-1 and MMP-2 is correlated with development,invasion and metastasis of esophageal carcinoma,and the Caveolin-1 might increase the activity of MMP-2.
出处 《实用肿瘤杂志》 CAS 北大核心 2011年第1期25-29,共5页 Journal of Practical Oncology
关键词 食管肿瘤 组织芯片 窖蛋白-1 基质金属蛋白酶 免疫组织化学 esophageal neoplasms tissue microarray Caveolin-1 matrix metalloproteinases immunohistochemistry
  • 相关文献

参考文献22

  • 1Arvelo F, Cotte C. Metalloproteinases in tumor progression [ J ]. Invest Clin,2006,47 (2) : 185 - 205.
  • 2Rothberg KG, Heuser JE, Donzell WC, et al. Caveolin, a protein component of caveolae membrane coats [ J ]. Cell, 1992,68 (4) :673 - 682.
  • 3漆楚波,朱润庆,夏和顺,王明伟.组织芯片简易制作方法及免疫组化有效性分析[J].肿瘤防治研究,2007,34(8):629-632. 被引量:17
  • 4Scherer PE, Lewis RY, Volonte D, et al. Cell-type and tissue-specific expression of eaveolin-2. Caveolin-1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo [ J ]. J Biol Chem, 1997,272 ( 46 ) : 29337 - 29346.
  • 5Galbiati F, Volonte D, Engelman JA, et al. Targeted downregulation of caveolin-1 is sufficient to drive transformation and hyperactivate the p42/44 MAP kinase cascade [ J ]. EMBO J, 1998,17 (22) :6633 - 6648.
  • 6Bender FC, Reymond MA, Bron C, et al. Caveolin-1 levels are down-regulated in human colon tumors, and ectopic expression of caveolin-1 in colon carcinoma cell lines reduces cell tumorigenicity [ J ]. Cancer Res, 2000, 60 (20) : 5870 - 5878.
  • 7Bagnoli M, Tomassetti A, Figini M, et al. Downmodulation of eaveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression [ J]. Oncogene ,2000,19(41 ) :4754 -4763.
  • 8Satoh T, Yang G, Egawa S, et al. Caveolin-1 expression is a predictor of recurrence-free survival in PT2N0 prostate carcinoma diagnosed in Japanese patients [ J ]. Cancer, 2003,97 (5) : 1225 - 1233.
  • 9Mouraviev V, Li L, Tahir SA, et al. The role of caveolin-1 in androgen insensitive prostate cancer [ J ]. J Urol, 2002,168(4) : 1589 - 1596.
  • 10Ando T, Ishiguro H, Kimura M, et al. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma [J]. Oncol Rep,2007,18 (3) :601 - 609.

二级参考文献27

  • 1蒋时红,刘旺根,王雪萍,张桂兰.组织芯片手工制作工具[J].解剖学杂志,2006,29(2):145-145. 被引量:7
  • 2张洪,邹伟.窖蛋白-1与乳腺癌[J].中国生物化学与分子生物学报,2007,23(1):20-26. 被引量:13
  • 3Jones JL,Walker RA. Control of matrix metalloproteinase activity in cancer[J]. ] Pathod, 1997,183(4) :377-379.
  • 4Parsons SL, Watson SA, Collins HM, et al. Gelatinase ( MMP-2and -9 ) expression in gastrointestinal malignancy [J]. Br J Cancer, 1998,78 ( 11 ) : 1495-1502.
  • 5Igarashi N,Takhashi M,Ohkubo H, et al. Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma[J]. Cancer, 1999,86(8) : 1 449-1 454.
  • 6Obashi K,Nemoto T,Nakamura K,et al.Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas[J].Cancer,2000,88(10):2201-2209.
  • 7Johnson N,Abonen M,Kahari V,et al.Matrix metalloproteinases in tumor invasion[J].Cell Mol Life Sci,2000,57(1):5-15.
  • 8Kim J,Yu W,Kovalski K,et al.Requirement of sedifid proteases in cancer cell intravasation as revealed by novel semiquantitative PCR-based assay[J].Cell,1988,94(3):353-362.
  • 9Pilcher B,Dumin J,Sudbeck B,et al.The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix[J].J Cell Biol,1997,137(6):1445-1457.
  • 10Koyama H,Iwata H,Kuwabara Y,et al.Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma:a study using in situ zymography[J].Eur J Cancer,2000 ,36(16):2164-2170.

共引文献30

同被引文献57

引证文献6

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部